Dr. Gabriel Akopian, MD

Dr. Akopian practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Akopian's NPI, 1326074535, was assigned on June 23, 2006. Dr. Akopian graduated from Boston University School Of Medicine in 2000. Dr. Akopian holds California license A79817.

Dr. Akopian's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Akopian's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Akopian is also affiliated with Huntington Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Akopian to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akopian practices. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Akopian's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Akopian is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Akopian's licenses on file in 2 states: California and Hawaii.

Dmand AI lists abdominal hernia repair surgery, colonoscopy, colon removal, gastrointestinal bleeding, groin hernia surgery and hemorrhoids among the conditions Dr. Akopian treats.

CMS data shows 378 Medicare services from Dr. Akopian across 12 procedure codes in 2024, for 154 Medicare patients. Medicare paid $24,537 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 154 Medicare patients who saw Dr. Akopian in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akopian's median patient age at 61, with 45% women.

In 2024, Dr. Akopian wrote 80 Medicare Part D claims for 35 patients. 99% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $191 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Akopian for performance year 2024, reported as part of a group. Dr. Akopian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Akopian as offering telehealth. CMS counts 67 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Akopian, more than 85% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Akopian, published from 2010 to 2025. The most frequent topics are Cholecystectomy, Laparoscopic, Postoperative Complications and Predictive Value of Tests. Dr. Akopian has published most often in Am Surg. Dr. Akopian's most frequent co-authors are Magdi G. Alexander, FACS, Howard S. Kaufman, MD and Rahim Aimaq, MD.

CMS Open Payments shows 171 general payments to Dr. Akopian from 33 drug and device companies from 2016 to 2025. Education make up the largest share, 54% of the total. Intuitive Surgical, Inc. paid the most, $12,435.

Dmand AI lists 1 award for Dr. Akopian.

Dr. Akopian graduated from Boston University School Of Medicine in 2000. Dr. Akopian is a member of ACS.

Dr. Akopian is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.